[{"ATTACHMENTNAME":"4479f3b7-f07d-40e3-a42e-c65938e2f552.pdf","NEWS_DT":"2022-10-27T11:19:17.893","QUARTER_ID":null,"CATEGORYNAME":"Company Update","HEADLINE":"Pursuant to Regulation 30(6) read with Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, the transcript of the Earnings call held on Friday, October 21, 2022 for the quarter and half year ended September 30, 2022 is available on the Company's website at:\r\n\r\nhttps://www.glenmarklifesciences.com/pdf/Transcript%20of%20Earnings%20Concall%20Q2%20FY2022-23.pdf\r\n\r\nThe said transcript is also attached.\r\n","SCRIP_CD":543322,"AGENDA_ID":157,"NEWSSUB":"Announcement under Regulation 30 (LODR)-Earnings Call Transcript"},{"ATTACHMENTNAME":"6d6593be-3b15-44bf-824a-865d6bd4b634.pdf","NEWS_DT":"2022-08-08T16:39:55.283","QUARTER_ID":null,"CATEGORYNAME":"Company Update","HEADLINE":"Pursuant to Regulation 30(6) read with Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, the transcript of the Earnings call held on Friday, 5th August, 2022 for the quarter ended June 30, 2022 is available on the Company's website at:\r\n\r\nhttps://www.glenmarklifesciences.com/pdf/Transcript%20of%20Earnings%20Concall%20Q1%20FY2022-23.pdf\r\n\r\nRequest you to kindly take the same on record.  \r\n","SCRIP_CD":543322,"AGENDA_ID":157,"NEWSSUB":"Announcement under Regulation 30 (LODR)-Earnings Call Transcript"}]